(Q36909266)

17 August 2017

1 reference

title

Stroke prevention in the high-risk patient (English)

1 reference

17 August 2017

J David Spence

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

1851-1859

1 reference

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Two decades of progress in preventing vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Nutrition and Stroke Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Counci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Individualized therapy for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: A primary role for beta blocking drugs such as propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Management of resistant hypertension in patients with carotid stenosis: high prevalence of renovascular hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Treatment options for renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Amiloride, a specific drug for hypertension in black people with T594M variant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Genetic variation in the epithelial sodium channel: a risk factor for hypertension in people of African origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Multistate utilization, processes, and outcomes of carotid endarterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Stroke prevention, blood cholesterol, and statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Homocysteine lowering and cardiovascular events after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Protected carotid-artery stenting versus endarterectomy in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Contents of Related Journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

Absence of Microemboli on Transcranial Doppler Identifies Low-Risk Patients With Asymptomatic Carotid Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1851

10.1517/14656566.8.12.1851

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference